Cynthia Morgan, MD
Rheumatology · Washington, DCNPI 1598701609
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,047 of the $2,407 with a category attached, or 85.1%. It is spread thinly across 15 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for rheumatology clinicians in DC, where the typical reported total is $3,462.
Across 93 payments — averaging $25.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$495
- GSK$453
- Amgen$449
- AstraZeneca$259
- UCB, Inc.$232
- Johnson & Johnson$184
- plus $335 from 9 others
What the payments were for
- Grants$24010%
- Food & beverage$2,04785%
- Education$1205%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 8 | $495 |
| GSK | 21 | $453 |
| Amgen(2 entities) | 22 | $449 |
| AstraZeneca(2 entities) | 11 | $259 |
| UCB, Inc. | 9 | $232 |
| Johnson & Johnson | 6 | $184 |
| Regeneron Healthcare Solutions, Inc. | 1 | $112 |
| Lilly USA, LLC | 4 | $60 |
| Hikma Pharmaceuticals USA | 4 | $59 |
| Genentech USA, Inc. | 2 | $38 |
| Zimmer Biomet | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Bioventus LLC | 1 | $13 |
| Pfizer | 1 | $13 |
| Novartis | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,407 in reported general payments places this provider in the 45th percentile of 41 rheumatology providers in District of Columbia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 14 | $204,570 |
| MethotrexateMethotrexate Sodium | 90 | $4,034 |
| Colchicine | 56 | $3,765 |
| Diclofenac Sodium | 87 | $3,347 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 72 | $2,583 |
| Hydroxychloroquine Sulfate | 70 | $2,418 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 99 | $2,029 |
| Lidocaine | 12 | $1,494 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 43 | $886 |
| Gabapentin | 60 | $688 |
| Prednisone | 78 | $651 |
| Celecoxib | 27 | $636 |
| Cyclobenzaprine Hcl | 36 | $619 |
| Naproxen | 25 | $521 |
| Tramadol Hcl | 89 | $385 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Washington
- Stephen MitchellWashington$1.6M
- Andrea Leonard-SegalWashington$633K
- Gail KerrWashington$244K
- Virginia SteenWashington$168K
- Sharon DowellWashington$73K
- Christopher CollinsWashington$69K
- Saira BilalWashington$62K
- Megan LockwoodWashington$23K
- Mercedes QuinonesWashington$23K
- Tayseer HarounWashington$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.